If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because ...
Keep Reading →
August 11 - Hedge Funds
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because ...
Keep Reading →
July 3 - Hedge Funds
"The S&P 500 and Nasdaq Composite struggled to remain in record territory Tuesday as investors sifted through mostly upbeat earnings reports amid a drop in oil prices and paid...
Keep Reading →
May 9 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
The Canadian market has had a decent year so far, with the benchmark S&P/TSX Composite Index gaining more than 12% for the year.
Keep Reading →
September 20 - Commodities, Hedge Funds, News
Pershing Square Holdings, the publicly traded security of activist investor Bill Ackman’s hedge fund, disclosed its second-quarter results Wednesday morning.
Keep Reading →
July 20 - Hedge Funds
Both Andreas Halvorsen and John Lykouretzos are former Tiger Cubs who once traded equities at Julian Robertson’s Tiger Management hedge fund.
Keep Reading →
June 29 - Hedge Funds, News
Activist hedge fund firm ValueAct Capital, has filed a 13D with the SEC revealing its ownership stake in Valeant Pharmaceuticals International Inc.
Keep Reading →
June 15 - Hedge Funds, News
According to a recent study by CIT, a reputable firm that is involved in financing and advisory services to the healthcare sector, healthcare executives seem rather optimistic...
Keep Reading →
May 26 - Hedge Funds, News
David Cohen and Harold Levy are founders of Iridian Asset Management. Messrs.
Keep Reading →
May 11 - Hedge Funds, News
Lee Ainslie’s Maverick Capital had one excellent quarter.
Keep Reading →
April 8 - Hedge Funds, News
CNBC's David Faber delivered the news that Allergan, Inc. (NYSE:AGN) is going to have a special shareholders' meeting on December 18th.
Keep Reading →
September 4 - Hedge Funds, News
Stephen Mandel’s Lone Pine Capital has revealed for the second quarter a portfolio of 67 companies worth $24.7 billion.
Keep Reading →
August 20 - Hedge Funds, News
Ken Squire's 13D Management is probably one of the most interesting funds to follow. The key point of its strategy involves tracking 13D filings of other investors.
Keep Reading →
May 27 - Hedge Funds, News
On Monday May 12, ValueAct Capital, managed by Jeffrey Ubben, declared the purchase of more than 2.95 million shares of Microsoft Corporation (NASDAQ:MSFT), which already is the...
Keep Reading →
May 13 - Hedge Funds, Insider Trading, News
As a newly amended filing with the SEC showed, Bill Ackman has reduced his exposure to Canadian Pacific Railway Limited (USA) (NYSE:CP), currently holding around 13.94 million...
Keep Reading →
April 30 - Hedge Funds, News
Bill Ackman's Pershing Square has added Allergan, Inc. (NYSE:AGN) to its equity portfolio.
Keep Reading →
April 22 - Hedge Funds, News
The 13F filings of Stephen Mandel, who manages Lone Pine Capital, reveal that his large-cap stock picks (those with market caps between above $20 billion) returned, on average...
Keep Reading →
April 7 - Hedge Funds, News
The Cooper Companies, Inc. (NYSE:COO), or more formally "The Cooper Companies" is a sort of odd duck in the med-tech world.
Keep Reading →
September 10 - News
The Cooper Companies, Inc.
Keep Reading →
September 4 - News
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
Keep Reading →
August 20 - News
A rising tide lifts all boats, but the opposite isn't true in the stock market. The major indexes slipped this week, while a handful of health-care stocks soared.
Keep Reading →
August 17 - News
Large healthcare companies are facing revenue declines due to expiring patents.
Keep Reading →
July 25 - News
According to IMS health report, the global pharmaceutical industry is expected to grow at a CAGR of 4.5% in the next five years to reach $1.20 trillion in 2017, from $963 billion...
Keep Reading →
July 2 - News
Courtesy of Insider Insights, I have compiled a list of significant insider/institutional purchases and sales that have been filed with the SEC over the last week--but does this...
Keep Reading →
July 2 - Insider Trading
The healthcare sector has always been a subject of great interest to investors and analysts alike.
Keep Reading →
June 21 - News
Botox may be best known for its ability to combat crow's feet and other facial wrinkles, but it also serves an important role in the medical community.
Keep Reading →
June 19 - News
Searching for potential stock investments can be a daunting task.
Keep Reading →
June 13 - Hedge Funds
While the debate goes on whether increasing output by acquiring new businesses through mergers, acquisitions and takeovers is the right way forward, the biopharmaceutical industry...
Keep Reading →
June 13 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been on an acquisition spree. Its latest purchase is Bausch + Lomb in an all-cash deal worth $8.7 billion.
Keep Reading →
June 12 - News
Everyone loves a defensive growth story, and there aren’t many better companies in the category than The Cooper Companies, Inc. (NYSE:COO).
Keep Reading →
June 12 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stirred the merger and acquisition space once again with its announcement that it is about to acquire multinational eye health firm...
Keep Reading →
June 10 - News
In one of the more surprising deals in some time, pork producer Smithfield Foods, Inc.
Keep Reading →
June 6 - News
If there were ever any advice I'd wish to impart to the management at Endo Health Solutions Inc (NASDAQ:ENDP)'s subsidiary Endo Pharmaceuticals, it would be that sometimes it'...
Keep Reading →
June 3 - News
The pharmaceutical industry is getting hotter with increasing M&A activities.
Keep Reading →
May 30 - News
For big companies like Apple Inc. (NASDAQ:AAPL) and Google Inc (NASDAQ:GOOG), it is unreasonable to expect that your shares will double in value.
Keep Reading →
May 30 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) jumped 8% on Monday, giving the stock a two-day 22% surge.
Keep Reading →
May 28 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has built a unique, winning drug business by acquiring underperforming niche product franchises and incorporating them into its efficient...
Keep Reading →
May 28 - News
Following the three-day holiday weekend, investors came back to work to find the stock market soaring, with the Dow Jones Industrials climbing more than 200 points by 10:45 a...
Keep Reading →
May 28 - News
News that Montreal-based Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was in talks to merge with Parsippany, New Jersey-based Actavis Inc (NYSE:ACT) emerged barely a week after...
Keep Reading →
May 15 - News
Roche Holding Ltd. (ADR) (PINK:RHHBY) and ISIS Pharmaceuticals, Inc.
Keep Reading →
April 8 - News
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom.
Keep Reading →
April 7 - News
The drug development field is a potentially lucrative, although always dangerous area for small companies and their investors to participate in.
Keep Reading →
March 27 - News
The Sequoia Fund is a mutual fund founded by William Ruane in 1970. Both Ruane and Warren Buffett took a class from Benjamin Graham, the father of value investing, in 1951.
Keep Reading →
March 22 - News
After reviewing the hedge fund filings for last quarter, there are five stocks that stood out as being loved by hedge funds. The hedge fund activity in these five stocks were...
Keep Reading →
March 15 - News
Endo Health Solutions Inc (NASDAQ:ENDP), a diversified healthcare company specializing in pain medication, has been sending out mixed signals recently.
Keep Reading →
February 26 - News
Endo Health Solutions Inc (NASDAQ:ENDP) shares popped more than 17% last week on rumors of exploratory talks with potential buyers including Valeant Pharmaceuticals Intl Inc (...
Keep Reading →
February 8 - News
I must confess I am finding the current market to be one of the most frustrating periods of my investing life.
Keep Reading →
February 8 - News
